Source: Blood. Conference titles: Annual Meeting and Exposition / ASH. Unidade: FM
Subjects: LINFOMA (ETIOLOGIA), FÁRMACOS IMUNOSSUPRESSORES, IMUNOHISTOQUÍMICA, PROGNÓSTICO
ABNT
LAGE, Luis Alberto de P. Covas et al. 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era. Blood. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://ash.confex.com/ash/2014/webprogram/Paper69673.html. Acesso em: 13 set. 2024. , 2014APA
Lage, L. A. de P. C., Hallack Neto, A. E., Santucci, R., Costa, R. O., Siqueira, S., Paula, H. M. de, & Pereira, J. (2014). 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era. Blood. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2014/webprogram/Paper69673.htmlNLM
Lage LA de PC, Hallack Neto AE, Santucci R, Costa RO, Siqueira S, Paula HM de, Pereira J. 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era [Internet]. Blood. 2014 ; 124( 21):[citado 2024 set. 13 ] Available from: https://ash.confex.com/ash/2014/webprogram/Paper69673.htmlVancouver
Lage LA de PC, Hallack Neto AE, Santucci R, Costa RO, Siqueira S, Paula HM de, Pereira J. 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era [Internet]. Blood. 2014 ; 124( 21):[citado 2024 set. 13 ] Available from: https://ash.confex.com/ash/2014/webprogram/Paper69673.html